Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs

Go back to Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs
(NYSE: LCTX) Delayed: 1.27 +0.01 (0.79%)
Previous Close $1.26    52 Week High
Open $1.24    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.24    EPS
Volume 491,073       

(NYSE: LCTX) Delayed: 1.27 +0.01 (0.79%)
Previous Close $1.26    52 Week High
Open $1.24    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.24    EPS
Volume 491,073